Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  37 results for ""Cobicistat""

Your Filters

Subject : combination drug therapy Filter by : Subject Phrase
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Dyslipidaemia after switch to tenofovir alafenamide (TAF)‐based cART regimens in a cohort of HIV‐positive patients: what clinical relevance?

Subjects: CARDIOVASCULAR diseases risk factors; COMBINATION drug therapy; CONFIDENCE intervals

  • Source: HIV Medicine; Feb2021, Vol. 22 Issue 2, p140-145, 6p

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia Cohort.

Subjects: ANTICOAGULANTS; COMBINATION drug therapy; DRUG interactions

  • Source: Clinical Infectious Diseases; 11/15/2020, Vol. 71 Issue 10, pe604-e613, 10p

Record details

Read More Add to Saved list
×
Academic Journal

Factors associated with the number of drugs in darunavir/cobicistat regimens.

Subjects: RITONAVIR; DARUNAVIR; HIV infectionsSPAIN

  • Source: Journal of Antimicrobial Chemotherapy (JAC); Jan2020, Vol. 75 Issue 1, p208-214, 7p

Record details

Read More Add to Saved list
×
Academic Journal

Cobicistat as a Pharmacoenhancer in Pregnancy and Postpartum: Progress to Date and Next Steps.

Subjects: COMBINATION drug therapy; GLYCOPROTEINS; PEPTIDESUNITED States. Food & Drug Administration

  • Source: Journal of Clinical Pharmacology; Jun2019, Vol. 59 Issue 6, p779-783, 5p

Record details

Read More Add to Saved list
×
Academic Journal

Bioequivalence of the Once‐Daily Single‐Tablet Regimen of Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Compared to Combined Intake of the Separate Agents and the Effect of Food on Bioavailability.

Subjects: BIOAVAILABILITY; TENOFOVIR; HIV

  • Source: Clinical Pharmacology in Drug Development; May2019, Vol. 8 Issue 4, p480-491, 12p

Record details

Read More Add to Saved list
×
Academic Journal

Reduced exposure to darunavir and cobicistat in HIV‐1‐infected pregnant women receiving a darunavir/cobicistat‐based regimen.

Subjects: COMBINATION drug therapy; COMPARATIVE studies; GESTATIONAL age

  • Source: HIV Medicine; May2019, Vol. 20 Issue 5, p337-343, 7p

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Effectiveness, Safety, and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus.

Subjects: COMBINATION drug therapy; MEDICATION safety; DRUG efficacy

  • Source: Infection & Chemotherapy; Sep2018, Vol. 50 Issue 3, p252-262, 11p

Record details

Read More Add to Saved list
×
Academic Journal

A Review of the Efficacy and Safety of Genvoya® (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) in the Management of HIV-1 Infection.

Subjects: THIAZOLES; EMTRICITABINE; HIV integrase inhibitors

  • Source: Journal of Pharmacy Practice; Apr2018, Vol. 31 Issue 2, p216-221, 6p

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients.

Subjects: PHARMACOKINETICS; DARUNAVIR; ETRAVIRINE (Drug)

  • Source: Journal of Antimicrobial Chemotherapy (JAC); Mar2018, Vol. 73 Issue 3, p732-737, 6p

Record details

Read More Add to Saved list
×
Academic Journal

Darunavir/cobicistat showing similar effectiveness as darunavir/ ritonavir monotherapy despite lower trough concentrations.

Subjects: COMBINATION drug therapy; DARUNAVIR; RITONAVIR

  • Source: Journal of the International AIDS Society; Feb2018, Vol. 21 Issue 2, p1-N.PAG, 6p, 2 Charts, 1 Graph

Record details

Read More Add to Saved list
×
  • 1-10 of  37 results for ""Cobicistat""